Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer

NCT03431415 is registered in ClinicalTrials.gov with Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec as lead sponsor.

NCT NCT03431415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03431415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer
Lead sponsor
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase
Not applicable
Overall status
Withdrawn
Start date
January 28, 2018
Completion date
February 28, 2025
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer stage i, stereotactic body radiation therapy, surgery